4/A: OptimizeRx CFO Corrects Shareholding in Amended SEC Filing

OptimizeRx's CFO, Edward Stelmakh, has amended a previous SEC filing to correct an understatement of his directly owned shares.

Summary

• This is an amended SEC Form 4 filing by Edward Stelmakh, CFO/COO of OptimizeRx Corp.
• The amendment corrects an error in a previous filing on April 24, 2024, where the number of directly owned shares was understated.
• The corrected filing shows that Mr. Stelmakh directly owns 33,365 shares of OptimizeRx common stock following the transaction on February 15, 2024.
• The original filing incorrectly stated the number of shares, which has now been rectified.
• Subsequent filings will also be corrected to reflect the accurate shareholding.

Sentiment

Score: 4

Explanation: The document corrects a previous error, which is a negative signal, but it is a routine filing and does not indicate any major issues.

Negatives

• The original SEC filing contained an error, understating the number of shares owned by the CFO.
• This error also affected subsequent filings, requiring further corrections.

Risks

• Inaccurate SEC filings can lead to regulatory scrutiny and potential penalties.
• Errors in reporting can erode investor confidence.

Industry Context

This type of filing is standard for company insiders who have transactions in their company's stock. It is a routine part of regulatory compliance.

Comparison to Industry Standards

• SEC Form 4 filings are a standard requirement for company insiders across all publicly traded companies in the US.
• The need for an amended filing indicates a deviation from the expected accuracy in reporting, which is generally considered a negative signal.
• Companies like Veeva Systems (VEEV) and IQVIA Holdings (IQV), which operate in similar sectors, also have their executives file similar forms, and any errors would be viewed similarly.

Stakeholder Impact

• Shareholders may have slightly reduced confidence due to the error in the original filing.
• The correction ensures transparency and compliance with regulations.

Next Steps

• The company will correct any subsequent filings affected by the original error.

Key Dates

Keywords

SEC Filing, Form 4, Beneficial Ownership, OptimizeRx, Shareholding, Amendment, Edward Stelmakh, CFO, OPRX